“When I was a plastic surgery resident in the early 2000s, leech therapy was already considered 'old but gold' — a treatment that seemed medieval but had modern scientific validation. Over 15 years, I've used medicinal leeches in hundreds of cases, and they've become an indispensable tool in my surgical armamentarium.”
Dr. Michael Chen, a board-certified plastic and reconstructive surgeon with 15 years of experience, shares his professional journey with medicinal leech therapy, from skeptical resident to advocate for evidence-based integration.
Medical Background
MD from Johns Hopkins (2006), integrated plastic surgery residency at Mass General (2006–2012), microsurgical reconstruction fellowship at MD Anderson (2012–2013). Currently Associate Professor of Plastic Surgery and Director of the Center for Microsurgical Reconstruction. Performs 300+ major reconstructive procedures annually, 40–60 free flap surgeries per year.
“Dr. Morrison explained the science — hirudin, anticoagulation, decompression. She showed me the literature. That night changed my perspective on what constitutes 'modern' medicine. Sometimes ancient wisdom meets modern science.”
15-Year Statistics
Total cases: 487. By indication: venous congestion in flaps 342 (70%), replantation 89 (18%), hematoma 38 (8%), other 18 (4%). Overall success rate (flap/limb salvage): 76%. Success with early intervention (<6 hours): 84%. Infection rate with prophylaxis: 3.2%. Transfusion rate: 28%.
“If you're doing free flap surgery and you're not prepared to use leech therapy, you're doing your patients a disservice. Venous congestion happens — to everyone. You need to have the tools to salvage the flap.”
Notable Cases
A 28-year-old with complete scalp avulsion (industrial accident): 12 leeches across scalp, 10-day treatment, 95% scalp survival with preserved hair growth. Bilateral DIEP flap congestion in BRCA1-positive patient: 12 leeches total, 7-day treatment, both flaps salvaged. Also learned from failure: head and neck flap where primary problem was arterial, not venous — taught the importance of distinguishing venous congestion from arterial insufficiency.
“This failure taught me more than many successes. You must distinguish venous congestion from arterial insufficiency. Leech therapy is contraindicated in arterial failure.”
Future of Leech Therapy
Research frontiers include anti-inflammatory applications, thrombosis prevention, wound healing enhancement, and pharmaceutical development of synthetic leech-derived compounds. Bivalirudin (synthetic hirudin analogue) is already used in cardiac catheterization.
“Leech therapy isn't alternative medicine — it's complementary medicine backed by science. As surgeons, we owe it to our patients to use every evidence-based tool available. Sometimes the most effective treatments come from unexpected places.”
Key Outcomes
Medical Perspective
Treating Physician
Dr. Michael Chen, MD, FACS
Plastic and Reconstructive Surgery
“Medicine isn't just about physiology and pharmacology. It's about human connection. When a patient trusts you enough to let leeches feed on their body, that's a profound expression of trust. I don't take that lightly.”
Medical Disclaimer
Individual results vary. These stories represent personal experiences and are not guarantees of outcome. Leech therapy requires proper medical supervision. Consult a qualified healthcare provider before starting any treatment.